ProStrakan receive FDA approval for Sancuso

ProStrakan Group has received FDA approval for Sancuso, it’s transdermal granisetron patch for the prevention of chemotherapy-induced nausea and vomiting (CINV).

Tracleer (bosentan) approved in EU for Pulmonary Arterial Hypertension

Actelion Ltd have announced today that its endothelin receptor antagonist Tracleer (bosentan) has been approved in the EU for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH)

FDA approves first generic risperidone

The FDA has approved the first generic versions of Risperdal (risperidone) tablets, manufactured by Teva.

FDA recommends approval of Tolvaptan for Hyponatremia

The FDA Advisory Committee on Cardiovascular and Renal Drugs has voted to recommend the approval of Otsuka’s V2-vasopressin receptor antagonist tolvaptan for the treatment of  hyponatremia.

Seroquel approved for Maintenance Treatment in Bipolar Disorder

The FDA has approved Seroquel (quetiapine fumarate) for the maintenance treatment of patients with bipolar I disorder. Seroquel is already approved by the FDA for the treatment of schizophrenia